You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Inside Higher Ed reports the graduate student union at the University of Michigan has ended its strike over the school's pandemic response.
A spontaneous coronary condition that is overrepresented in young women had a polygenic risk score linked to lower-than-usual atherosclerosis-related heart disease risk.
Wired reports that coronavirus pandemic and the ensuing lab shutdowns and policy changes are having an effect on the careers of young researchers.
RenalytixAI's flagship product is KidneyIntelX, which applies artificial intelligence to patient data to aid in the treatment of progressive kidney disease.
Two studies presented at ASCO's virtual annual meeting demonstrated the clinical utility of germline findings in guiding treatment decisions in cancer.
In Nature this week: method to uncover genetic components of complex traits, novel cytosine base editor, and more.
A pilot project showed that clinics using the InheRET tool were able to gather more complete family history information from patients, which is important for further cancer risk evaluation.
In Nucleic Acids Research this week: prostate cancer drugs' effect on androgen receptors, approach to gauge effects of epigenetic drugs, and more.
In Nature this week: sequencing analysis finds some cells in the lungs of former smokers have mutational burdens that were equivalent to those of never-smokers, and more.
In a large group of participants followed for decades, baseline body mass index outperformed a SNP-based obesity risk score for predicting midlife weight.
The head of Operation Warp Speed tells Bloomberg he expects the paused AstraZeneca and Johnson & Johnson vaccine trials to resume soon.
A new UK government says socioeconomic factors, not genetics, account for disparities in deaths due to COVID-19 between ethnic groups, the Financial Times reports.
NPR reports on an Alzheimer's disease drug trial that is continuing despite the pandemic.
In Nature this week: CRISPR-Cas3 system for making large deletions efficiently, more.